Spike S protein library |
SB043 |
Smartox Biotechnology |
0.5 |
EUR 2326.75 |
Description: Spike (S) glycoprotein corresponds to one of the leading targets for COVID-19 disease. Present on the surface of Sars-CoV-2 virus, Spike S protein is a class I fusion protein that allows the virus to enter host cells.With a 1 273 aa length, Spike protein has 2 subunits : S1 contains the receptor-binding domain RBD and S2 induces the fusion of the viral envelop with the cellular membrane. The S1 subunit allows binding to the Angiotensin-Converting Enzyme receptor 2 (ACE2 receptor) which mediates the viral entry.Spike (S) is a glycoprotein of 1 273 aa length. sb-PEPTIDE offers a library made of 316 peptides with a length of 15 amino acids and an overlap of 11 amino acids without post-translational modificaton. |
Human IgG antibody Laboratories manufactures the ace2 spike s protein reagents distributed by Genprice. The Ace2 Spike S Protein reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact Spike Protein. Other Ace2 products are available in stock. Specificity: Ace2 Category: Spike Group: S Protein
Human coronavirus OC43 Spike glycoprotein (S) |
Cusabio |
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
|
- 10ug
- 50ug
- 100ug
- 200ug
- 500ug
- 1MG
|
|
Description: Recombinant Human coronavirus OC43 Spike glycoprotein(S) ,partial expressed in Yeast |
Spike S peptide pool |
Smartox Biotechnology |
15 nmol |
EUR 409.06 |
Description: Spike S peptide is a peptide pool made of 15-mer peptides with 11–amino acid (aa) overlap, covering the complete sequence of the Spike S protein. |
Recombinant Human Novel Coronavirus Spike glycoprotein (S) Protein |
MyBiosource |
0.1mg |
EUR 1240 |
Recombinant Human Novel Coronavirus Spike glycoprotein (S) Protein |
MyBiosource |
0.5mg |
EUR 3045 |
Recombinant Human Novel Coronavirus Spike glycoprotein (S) Protein |
MyBiosource |
1mg |
EUR 4355 |
Recombinant Human Novel Coronavirus Spike glycoprotein (S) Protein |
MyBiosource |
5x1mg |
EUR 19595 |
Recombinant Human Novel Coronavirus Spike glycoprotein (S) Protein |
MyBiosource |
0.1mg |
EUR 1240 |
S Protein information
Spike S1-Biotin (SARS-CoV-2): ACE2 TR-FRET Assay Kit |
79949-1 |
BPS Bioscience |
96 rxns. |
EUR 905 |
Description: The pandemic coronavirus disease 2019 (COVID-19) is caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). As a first step of the viral replication strategy, the virus attaches to the host cell surface before entering the cell. The Spike protein recognizes and attaches to the Angiotensin-Converting Enzyme 2 (ACE2) receptor found on the surface of type I and II pneumocytes, endothelial cells, and ciliated bronchial epithelial cells. Drugs targeting the interaction between the Spike protein of SARS-CoV-2 and ACE2 may offer some protection against the viral infection._x000D_The SARS-CoV-2 Spike S1:ACE2 TR-FRET Assay is designed to measure the inhibition of the binding between SARS-CoV-2 Spike S1 and human ACE2 in a homogeneous 96 or 384 reaction format. This TR-FRET-based assay requires no time-consuming washing steps, making it especially suitable for high throughput screening applications. The assay procedure is straightforward and simple; the test inhibitor compound is incubated with biotinylated Spike S1, Eu-labeled ACE2, dye-labeled acceptor and an inhibitor for one hour. Then the TR-FRET signal is measured using a fluorescence reader._x000D_ |
Spike S1-Biotin (SARS-CoV-2): ACE2 TR-FRET Assay Kit |
79949-2 |
BPS Bioscience |
384 rxns. |
EUR 1265 |
Description: The pandemic coronavirus disease 2019 (COVID-19) is caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). As a first step of the viral replication strategy, the virus attaches to the host cell surface before entering the cell. The Spike protein recognizes and attaches to the Angiotensin-Converting Enzyme 2 (ACE2) receptor found on the surface of type I and II pneumocytes, endothelial cells, and ciliated bronchial epithelial cells. Drugs targeting the interaction between the Spike protein of SARS-CoV-2 and ACE2 may offer some protection against the viral infection._x000D_The SARS-CoV-2 Spike S1:ACE2 TR-FRET Assay is designed to measure the inhibition of the binding between SARS-CoV-2 Spike S1 and human ACE2 in a homogeneous 96 or 384 reaction format. This TR-FRET-based assay requires no time-consuming washing steps, making it especially suitable for high throughput screening applications. The assay procedure is straightforward and simple; the test inhibitor compound is incubated with biotinylated Spike S1, Eu-labeled ACE2, dye-labeled acceptor and an inhibitor for one hour. Then the TR-FRET signal is measured using a fluorescence reader._x000D_ |
2019 nCoV/COVID19 Spike protein S Recombinant-His |
MBS553721-01mg |
MyBiosource |
0.1mg |
EUR 490 |
2019 nCoV/COVID19 Spike protein S Recombinant-His |
MBS553721-05mg |
MyBiosource |
0.5mg |
EUR 1570 |
2019 nCoV/COVID19 Spike protein S Recombinant-His |
MBS553721-5x05mg |
MyBiosource |
5x0.5mg |
EUR 6775 |
SARS Associated Spike Mosaic S(M) Protein |
20-abx260155 |
Abbexa |
-
Ask for price
-
Ask for price
-
Ask for price
|
|
|
SARS Associated Spike Mosaic S(M) Protein |
abx260155-20g |
Abbexa |
20 µg |
EUR 950 |
SARS Associated Spike Mosaic S(M) Protein |
abx260155-5g |
Abbexa |
5 µg |
EUR 350 |
SARS Associated Spike Mosaic S(N) Protein |
20-abx260157 |
Abbexa |
-
Ask for price
-
Ask for price
-
Ask for price
|
|
|
SARS Associated Spike Mosaic S(N) Protein |
abx260157-20g |
Abbexa |
20 µg |
EUR 950 |
SARS Associated Spike Mosaic S(N) Protein |
abx260157-5g |
Abbexa |
5 µg |
EUR 350 |
Spike S1 RBD (SARS-CoV-2): ACE2 Inhibitor Screening Assay Kit |
79931 |
BPS Bioscience |
96 rxns. |
EUR 675 |
Description: The SARS-CoV-2 Spike:ACE2 Inhibitor Screening Assay Kit is designed for screening and profiling inhibitors of this interaction. The key to this kit is the high sensitivity of detection of bound His-labeled ACE2 by HRP-labeled Anti-His. Only a few simple steps on a microtiter plate are required for the assay. First, SARS-CoV-2 Spike is coated on a 96-well plate. Next, ACE2-His is incubated with SARS-CoV-2 Spike on the plate. Finally, the plate is treated with Anti-His-HRP followed by addition of an HRP substrate to produce chemiluminescence, which then can be measured using a chemiluminescence reader. |
Biotinylated SARS COV2 Spike protein S Trimer Recombinant |
MBS553736-002mg |
MyBiosource |
0.02mg |
EUR 515 |
Biotinylated SARS COV2 Spike protein S Trimer Recombinant |
MBS553736-01mg |
MyBiosource |
0.1mg |
EUR 1435 |
ACE2:Spike RBD (SARS-CoV-2) Inhibitor Screening Colorimetric Assay Kit |
78031 |
BPS Bioscience |
96 rxns. |
EUR 630 |
Description: Coronavirus disease 2019 (COVID-19) increases the risk of developing Acute Respiratory Distress Syndrome (ARDS), which is often fatal at the late stages of the infection when the SAR-CoV-2 virus causes significant damage to the lungs. As a first step of the viral replication strategy, the virus attaches to the host cell surface before entering the cell. The Spike protein receptor binding domain (RBD) recognizes and attaches to the Angiotensin-Converting Enzyme 2 (ACE2) receptor found on the surface of type I and II pneumocytes, endothelial cells, and ciliated bronchial epithelial cells. Drugs targeting the interaction between the Spike protein of SARS-CoV-2 and ACE2 may offer some protection against the viral infection.The ACE2:SARS-CoV-2 Spike (RBD) Inhibitor Screening Colorimetric Assay Kit is designed for screening and profiling inhibitors of this interaction. The key to this kit is the high sensitivity of detection of Fc-tagged Spike protein by HRP-labeled Anti-mouse-Fc. Only a few simple steps on a microtiter plate are required for the assay. First, ACE2 protein is attached to a clear nickel-coated 96-well plate. Next, SARS-CoV-2 Spike-Fc is incubated with ACE2 on the plate. Finally, the plate is treated with HRP-labeled anti-Fc, followed by addition of an HRP substrate to produce color, which can then be measured using a UV/Vis spectrophotometer microplate reader. |
COV2 Spike protein S B.1.1.529 (Omicron) Biotinylated-His |
MBS553746-002mg |
MyBiosource |
0.02mg |
EUR 490 |
COV2 Spike protein S B.1.1.529 (Omicron) Biotinylated-His |
MBS553746-01mg |
MyBiosource |
0.1mg |
EUR 1570 |